Considering the role of adaptive immunity in anti-tumor responses, and T cells playing a crucial role in adaptive immunity against cancer, we further analyzed the proportion of CD4+ and CD8+ T cells in peripheral blood after the treatments. The gene discussed is CD8A; the disease is neoplasm.